1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Investors have a love-hate relationship with low-priced stocks. Most institutions avoid stocks that sell in the single digits, mainly because they are hard to trade in large quantities. Many individual...
These companies are putting a troubled past behind them. The stocks are risky, but they offer big opportunities.
According to top analysts on the Street, these five “Strong Buy” biotech stocks are primed for outsized growth in the next 12 months.
Biotechs often present intriguing, and potentially...
More Investing News »